A study published in the journal Nature Medicine flooded mainstream media and Facebook feeds this week with headlines and stories claiming that a blood test may be able to detect Alzheimer’s disease (AD) more than a decade before symptoms appear. One caveat overlooked or downplayed by many outlets, though: The study population involved individuals with a rare gene mutation that made them highly likely to develop AD. “They are also generally significantly younger when they do,” PMC Co-Director David Wolk, MD, explained. “Such patients make up less than 1 percent of AD. So it remains to be seen how well this test will work in older individuals with more typical AD, but it is certainly promising as a marker of brain injury over time.” This injury could be due to Alzheimer’s disease but also many other brain diseases, added PMC Co-Director Jason Karlawish, MD.
In short: No, there is not yet a blood test able to predict Alzheimer’s.
For a more in-depth, but simplified, breakdown of the research, its results, and conclusions, refer to this article from the British Department of Health and Social Care (DHSC). To learn more about biomarkers currently being used in AD care and research, visit the National Institute on Aging. |
|||||
|
|||||
|